Using Stereotactic Body Radiation Therapy for Kidney Cancer
Author Information
Author(s): Teh BS, Bloch C, Galli-Guevara M, Doh L, Richardson S, Chiang S, Yeh P, Gonzalez M, Lunn W, Marco R, Jac J, Paulino AC, Lu HH, Butler EB, Amato RJ
Primary Institution: Department of Radiation Oncology, The Methodist Hospital, Houston, Texas, United States
Hypothesis
Can image-guided stereotactic body radiation therapy (SBRT) effectively treat primary and metastatic renal cell carcinoma (RCC)?
Conclusion
Image-guided SBRT provides excellent symptom relief and local control without significant toxicity.
Supporting Evidence
- 93% of patients with extra-cranial metastases achieved significant pain relief.
- Local control rate was 87% after treatment.
- Patients reported improvement in quality of life and reduced need for pain medications.
- There were no significant treatment-related side effects observed.
Takeaway
Doctors used a special type of radiation therapy to help patients with kidney cancer feel better and control their tumors without hurting them.
Methodology
Patients were treated with SBRT using the Brainlab Novalis system, with image guidance and various radiation doses over 3-6 fractions.
Limitations
The study had a small number of patients and short follow-up time.
Participant Demographics
Patients included 14 with metastatic RCC and 2 with primary RCC, all with various medical issues.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website